CD4 and psoriasis: Mechanistically, TGF-β/IL-23 induces hypoxia-inducible factor-1α (HIF-1α), which recruits the histone acetyltransferase P300 to the miR-210 promoter region, thereby enhancing miR-210 expression in CD4+ T cells from psoriasis patients (13, 65).